Amniotic Membrane Dressings Reduce Infection Transfer in Burn Patients
Chronic burn wounds lead to trauma amongst patients. What adds to the patient’s difficulty is the risk of infection, sepsis, joint problems, and scarring during the management of third-degree burns. Hence, healthcare industries are increasing awareness about amniotic membranes (AM), since these membranes have gained the approval of many health commissions across various countries.
Healthcare providers in the amniotic membrane market are increasingly using fresh amniotic membranes as dressings on burn areas. It has been found that, serology and virology tests validate the use of frozen amnion membrane dressings to minimize the risks of infection transfer. Companies in the amniotic membrane market are increasing the availability of amnion membranes to facilitate the reepithelization of burn wounds. Incremental opportunities related to burn wounds are likely to grow, since the overall surgical wounds domain accounts for the highest revenue amongst all applications in the amniotic membrane market, with a predicted value of ~US$ 1.2 billion by 2027.
The growing trend of amniotic membranes enriched with stem cells is gaining traction in the healthcare landscape. This trend is anticipated to grow even further, since it has been found that, amniotic membrane dressings significantly reduce pain in burn patients.
To know the scope of our report Get a Sample on Amniotic Membrane Market
Companies Innovate in Stem Cell-induced hAM for Cardiac Tissue Regeneration
There is growing demand for human amniotic membranes (hAM) for cardiac tissue regeneration. Hence, healthcare companies in the amniotic membrane market fostering innovation in human-induced pluripotent stem cell (hiPSC)-derived cardiac muscle cells for successful cardiac tissue regeneration. This technique is pervasively becoming a treatment alternative to gelatin-based 3D matrix matrigel protein.
Heart attacks can lead to necrosis of the cardiac tissue. This trend has become a driver for the amniotic membrane market, since increasing rates of heart failures have led to several deaths, worldwide. Individuals are becoming increasingly aware about hAM. Hence, companies in the amniotic membrane market are increasing the availability of hAM in hospitals and ambulatory surgical centers to aid successful regeneration of injured cardiac tissue.
Healthcare companies are focusing on innovation regarding the combination of stem cells and synthetic materials for cardiac tissue regeneration. Decellularized biological matrices are also emerging as a useful alternative for tissue regeneration.
Locally Available Amniotic Allografts Increasingly Meeting Needs of Patients with Joint Pain
Foot pain is one of the most common orthopedic complaints in the healthcare landscape. To cater to this prevalent health condition, healthcare industries are developing improved amniotic allografts to reduce joint and soft tissue pain. The introduction of amniotic allografts has helped reduce pain and enhance healing in patients suffering from foot and ankle pain.
Growing incidence of repeated trauma and joint pain in the feet has triggered the demand for amniotic allografts. Healthcare providers are providing relief to patients after several clinical trials through musculoskeletal ultrasound, electromyography and computerized tomography scans. Amniotic allografts are becoming increasingly popular amongst patients, since this technique provides long-term relief, unlike the conventional non-operative management of joint pain.
Get a glimpse of the in-depth analysis through our Report Brochure
Locally available amnion mesenchymal cell injections are creating incremental opportunities for healthcare companies, since these injections help in the healing of injured peripheral nerves.
HAAM-based Approach Becomes Increasingly Suitable for Treatment of Skin Wounds
The lower third of the nose is one of the most important cosmetic units as far as the face is concerned. However, reconstruction techniques for the same remain a challenge for healthcare industries in the amniotic membrane space.
Human acellular amniotic membrane (HAAM) implantation serves as an effective approach for lower third nasal reconstruction. Companies in the amniotic membrane market are carrying out extensive investigations to closely study this biomaterial-based strategy. However, in many cases, HAAM leads to full-thickness defects after the surgical procedure. Lack of research studies make it unclear whether the locations of the wound affect the healing potential of HAAM. To overcome these challenges, healthcare industries in the amniotic membrane market are increasing efforts to establish a standardized process for HAAM that can aid its adoption for future clinical use.
Altogether, HAAM is found to have a promising approach for treating various skin defects. Hence, healthcare industries are increasing its application in the amniotic membrane market for repairing skin wounds. They are increasing their R&D efforts to study the safety and efficacy of HAAM for burn wounds and diabetic foot ulcers.
Expanding operations in future? To get the perfect launch ask for a custom report
Analysts’ Viewpoint
The amniotic membrane market is highly consolidated in nature, with only four major players accounting for ~70% of the market share. Companies are increasing their presence in inorganic strategies such as commercializing their product portfolios. For instance, in August 2018, MiMedx - a leader in placental-based products, revealed that it had received regulatory approval to commercialize its product portfolio in dehydrated human amnion/chorion membrane (dHACM) products in Australia.
However, complications associated with amniotic membranes, such as post AM transplantation infection and premature degeneration, are likely to hamper market growth. To win over these hurdles, companies should increase R&D related to the orientation of AM with useful techniques such as sutureless AM in clinical-based setting.
Amniotic Membrane Market and Report Description
- Cryopreserved amniotic membranes and lyophilization amniotic membranes are the two types of amniotic membranes are used in wound healing and ophthalmology applications.
- Amniotic membrane transplantation is used as a graft or dressing in different surgical procedures to reduce inflammation and promote wound healing. Cryopreserved amniotic membranes are primarily used in ocular surface surgeries, as cryopreservation preserves the biological structure, including the cells and other organelles by cooling them to very low temperatures.
- Amniotic membranes are used in ophthalmology to reconstruct the ocular surface after various surgical procedures, as a graft for ocular surface melts, or as a bandage to promote healing in cases of persistent epithelial defects or ocular surface inflammation. The application of amniotic membranes in ophthalmology has increased significantly in the past few years.
- Amniotic membrane transplantation is used in surgical wounds as a graft or dressing material in different surgical subspecialties.
- Rise in the number of trauma cases, burn injuries, and ophthalmic disorders are projected to drive the global amniotic membrane market during the forecast period.
- The global amniotic membrane market is projected to expand at a healthy CARG of ~10% from 2019 to 2027.
Global Amniotic Membrane Market: Drivers
- Increase in number of accident and trauma cases drive the global amniotic membrane market. Human amniotic membrane has wide range of applications including treatment of ocular surface disorders and wound healing. According to the World Health Organization (WHO), an estimated 180,000 deaths are caused by burns each year, with majority occurring in low- and middle-income countries and two third in Africa and Southeast Asia.
- Amniotic membrane (AM) transplantation as a permanent surgical graft has shown to promote epithelialization and reduce inflammation, scarring, and neovascularization. Amniotic membranes are also used as temporary patch or biological bandage for acute chemical burns.
- Governments of several countries fund stem cell/regenerative medicine studies. This factor propels the global amniotic membrane market.
- Based on the Government Accountability Office data, approximately US$ 2.89 Bn was invested by seven federal agencies for regenerative medicine research from 2012 to 2014. Of this, 88% was invested by the National Institutes of Health. Government initiatives to spread awareness about usage of amniotic membrane is likely to propel the global amniotic membrane market in the near future.
- Rise in government initiatives and continuous funding is expected to boost the growth of the global amniotic membrane market
Global Amniotic Membrane Market: Key Segments
- The cryopreserved amniotic membrane dominated the global amniotic membrane market in 2018. Cryopreservation preserves biological constructs such as cells and organelles by cooling the sample to a very low temperature, and cryopreserved amniotic membranes aid wound healing.
- The surgical wounds segment dominated the global amniotic membrane market in 2018. Rise in the number of sport- and fall-related injuries is expected to drive the growth of the segment over the period of forecast. It is anticipated to create high incremental opportunity in the global amniotic membrane market during the forecast period.
- Rise in the number of accident cases and trauma injuries in several countries makes hospitals a major end user of the amniotic membrane market. Growth of the segment can be attributed to rise in the rate of hospitalization and wide range of services offered at a single site.
Global Amniotic Membrane Market: Competition Analysis
- The global amniotic membrane market report concludes with the company profiles section that includes key information about the major players in the market.
- Leading players analyzed in the amniotic membrane market report are
- Integra LifeSciences
- MiMedx
- Skye Biologics, Inc.
- Katena Products, Inc.
- Amnio Technology
- LLC
- Applied Biologics
- TissueTech, Inc.
- Stryker
- Osiris Therapeutics, Inc.
- Human Regenerative Technologies
- Each of these players has been profiled in the global amniotic membrane market report based on parameters such as company overview, financial overview, business strategy, product portfolio, business segment, and recent developments.
- In February 2017, Integra LifeSciences acquired Derma Sciences to strengthen its tissue regeneration segment. This breakthrough therapy enabled the company to enhance its regenerative tissue product line, and treat a diverse population with wound healing properties.
- Development of innovative new products through robust R&D, global expansion through wide distribution network, and mergers & acquisitions are key strategies adopted by leading players in the global market. Several companies are focusing on new product launches and mergers & acquisitions on a global level.
- In August 2018, MiMedx received regulatory approval from the Therapeutics Goods Administration (TGA) in Australia for distributing dehydrated human amnion/chorion membrane (dHACM) products.
Amniotic Membrane Market - Scope of the Report
TMR’s report on the global amniotic membrane market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators for the said market for the forecast period of 2019 to 2027. The report provides revenue of the global amniotic membrane market for the period of 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global amniotic membrane market from 2019 to 2027.
The report has been prepared after extensive research. Primary research involves bulk of the research efforts, wherein, analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involves referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global amniotic membrane market.
Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of the top-down and bottom-up approach to study various attributes of the global amniotic membrane market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global amniotic membrane market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global amniotic membrane market.
The report delves into the competitive landscape of the global amniotic membrane market. Key players operating in the global amniotic membrane market have been identified and each one of them has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of the players in the global amniotic membrane market that have been profiled in this report.
Key Questions Answered in Amniotic Membrane Market Report
- What is the sales/revenue expected to be generated by the amniotic membrane market across all regions during the forecast period?
- What are the opportunities in the global amniotic membrane market?
- What are the major drivers, restraints, opportunities, and threats in the global market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which product segment is expected to generate the highest revenue, globally, in 2027? Which segment is projected expand at the highest CAGR during the forecast period?
- What is the market position of different companies operating in the global market?
Amniotic Membrane Market - Research Objectives and Research Approach
The comprehensive report on the global amniotic membrane market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study, key vendors and distributors operating in the market, and regulatory scenario for the approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that have been appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Europe
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Global Amniotic Membrane Market - Segmentation
TMR’s study on the global amniotic membrane market includes information divided into four segments: product, application, end user, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global amniotic membrane market have been discussed in detail.
|
Product |
Cryopreserved Amniotic Membrane Lyophilization Amniotic Membrane |
|
Application |
Surgical Wounds Ophthalmology Others |
|
End User |
Hospitals Ambulatory Surgical Centers Specialized Clinics Research Centers & Laboratories |
|
Region |
North America Europe Asia Pacific Latin America Middle East & Africa |
With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.
TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.
Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:
Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.
Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.
Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Amniotic Membrane Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Amniotic Membrane Market Analysis and Forecast, 2017–2027
5. Key Insights
5.1. Clinical Trial Analysis
5.2. Regulatory Scenario of Amniotic Membrane Products
5.3. Reimbursement Scenario of Amniotic Membrane
6. Global Amniotic Membrane Market Analysis and Forecasts, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
6.3.1. Cryopreserved Amniotic Membrane
6.3.2. Lyophilization Amniotic Membrane
6.4. Global Amniotic Membrane Market Attractiveness, by Product
7. Global Amniotic Membrane Market Analysis and Forecasts, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Amniotic Membrane Market Value (US$) Forecast, by Application, 2017–2027
7.3.1. Surgical Wounds
7.3.2. Ophthalmology
7.3.3. Others
7.4. Global Amniotic Membrane Market Attractiveness, by Application
8. Global Amniotic Membrane Market Analysis and Forecasts, by End User
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Specialized Clinics
8.3.4. Research Centers & Laboratories
8.4. Global Amniotic Membrane Market Attractiveness, by End User
9. Global Amniotic Membrane Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Global Amniotic Membrane Market Value (US$ Mn) Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Amniotic Membrane Market Attractiveness, by Region
10. North America Amniotic Membrane Market Analysis and Forecast
10.1. Introduction
10.2. North America Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
10.2.1. Cryopreserved Amniotic Membrane
10.2.2. Lyophilization Amniotic Membrane
10.3. North America Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
10.3.1. Surgical Wounds
10.3.2. Ophthalmology
10.3.3. Others
10.4. North America Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Specialized Clinics
10.4.4. Research Centers & Laboratories
10.5. North America Amniotic Membrane Market Value (US$ Mn) Forecast, by Country, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America Amniotic Membrane Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End User
10.6.4. By Country
11. Europe Amniotic Membrane Market Analysis and Forecast
11.1. Introduction
11.2. Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
11.2.1. Cryopreserved Amniotic Membrane
11.2.2. Lyophilization Amniotic Membrane
11.3. Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
11.3.1. Surgical Wounds
11.3.2. Ophthalmology
11.3.3. Others
11.4. Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Specialized Clinics
11.4.4. Research Centers & Laboratories
11.5. Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Amniotic Membrane Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End User
11.6.4. By Country/Sub-region
12. Asia Pacific Amniotic Membrane Market Analysis and Forecast
12.1. Introduction
12.2. Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
12.2.1. Cryopreserved Amniotic Membrane
12.2.2. Lyophilization Amniotic Membrane
12.3. Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
12.3.1. Surgical Wounds
12.3.2. Ophthalmology
12.3.3. Others
12.4. Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Specialized Clinics
12.4.4. Research Centers & Laboratories
12.5. Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Amniotic Membrane Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End User
12.6.4. By Country/Sub-region
13. Latin America Amniotic Membrane Market Analysis and Forecast
13.1. Introduction
13.2. Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
13.2.1. Cryopreserved Amniotic Membrane
13.2.2. Lyophilization Amniotic Membrane
13.3. Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
13.3.1. Surgical Wounds
13.3.2. Ophthalmology
13.3.3. Others
13.4. Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Specialized Clinics
13.4.4. Research Centers & Laboratories
13.5. Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Amniotic Membrane Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End User
13.6.4. By Country/Sub-region
14. Middle East & Africa Amniotic Membrane Market Analysis and Forecast
14.1. Introduction
14.2. Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
14.2.1. Cryopreserved Amniotic Membrane
14.2.2. Lyophilization Amniotic Membrane
14.3. Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
14.3.1. Surgical Wounds
14.3.2. Ophthalmology
14.3.3. Others
14.4. Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
14.4.1. Hospitals
14.4.2. Ambulatory Surgical Centers
14.4.3. Specialized Clinics
14.4.4. Research Centers & Laboratories
14.5. Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
14.5.1. GCC
14.5.2. South Africa
14.5.3. Israel
14.5.4. Rest of Middle East & Africa
14.6. Middle East & Africa Amniotic Membrane Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Application
14.6.3. By End User
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Share Analysis, by Company, 2018
15.2. Company Profiles
15.2.1. Integra LifeSciences
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Company Financials
15.2.1.3. Growth Strategies
15.2.1.4. SWOT Analysis
15.2.2. MiMedx
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Company Financials
15.2.2.3. Growth Strategies
15.2.2.4. SWOT Analysis
15.2.3. Skye Biologics, Inc.
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Growth Strategies
15.2.3.3. SWOT Analysis
15.2.4. Katena Products, Inc.
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Growth Strategies
15.2.4.3. SWOT Analysis
15.2.5. Amnio Technology, LLC
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Growth Strategies
15.2.5.3. SWOT Analysis
15.2.6. Applied Biologics
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Growth Strategies
15.2.6.3. SWOT Analysis
15.2.7. TissueTech, Inc.
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Growth Strategies
15.2.7.3. SWOT Analysis
15.2.8. Stryker
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Company Financials
15.2.8.3. Growth Strategies
15.2.8.4. SWOT Analysis
15.2.9. Osiris Therapeutics, Inc.
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Company Financials
15.2.9.3. Growth Strategies
15.2.9.4. SWOT Analysis
15.2.10. Human Regenerative Technologies, LLC
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Growth Strategies
15.2.10.3. SWOT Analysis
List of Tables
Table 01: Global Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 02: Global Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 03: Global Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 04: Global Amniotic Membrane Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 05: North America Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 06: North America Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 07: North America Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 08: North America Amniotic Membrane Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 09: Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 10: Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 11: Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 12: Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 13: Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 14: Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 15: Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 16: Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 17: Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 18: Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 19: Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 20: Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 21: Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 22: Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 23: Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 24: Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
List of Figures
Figure 01: Global Amniotic Membrane Market Size (US$ Mn) and Distribution, by Region, 2018 and 2027
Figure 02: Global Amniotic Membrane Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 03: Brand Wise Number of Clinical Trials per Product, 2017
Figure 04: Number of Clinical Trials for Amniotic Membrane Products - Company wise, 2017
Figure 05: Global Amniotic Membrane Market Value Share Analysis, by Product, 2018 and 2027
Figure 06: Global Amniotic Membrane Market Value (US$ Mn) and Y-o-Y Growth (%), by Cryopreserved Amniotic Membrane, 2017–2027
Figure 07: Global Amniotic Membrane Market Value (US$ Mn) and Y-o-Y Growth (%), by Lyophilization Amniotic Membrane, 2017–2027
Figure 08: Global Amniotic Membrane Market Attractiveness Analysis, by Product, 2019–2027
Figure 09: Global Amniotic Membrane Market Value Share Analysis, by Application, 2018 and 2027
Figure 10: Global Amniotic Membrane Value (US$ Mn) and Y-o-Y Growth (%), by Surgical Wounds, 2017–2027
Figure 11: Global Amniotic Membrane Value (US$ Mn) and Y-o-Y Growth (%), by Ophthalmology, 2017–2027
Figure 12: Global Amniotic Membrane Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027
Figure 13: Global Amniotic Membrane Market Attractiveness Analysis, by Application, 2019–2027
Figure 14: Global Amniotic Membrane Market Value Share Analysis, by End User, 2018 and 2027
Figure 15: Global Amniotic Membrane Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027
Figure 16: Global Amniotic Membrane Market Value (US$ Mn) and Y-o-Y Growth (%), by Ambulatory Surgical Centers, 2017–2027
Figure 17: Global Amniotic Membrane Market Value (US$ Mn) and Y-o-Y Growth (%), by Specialized Clinics, 2017–2027
Figure 18: Global Amniotic Membrane Market Value (US$ Mn) and Y-o-Y Growth (%), by Research Centers & Laboratories, 2017–2027
Figure 19: Global Amniotic Membrane Market Attractiveness Analysis, by End User, 2019–2027
Figure 20: Global Amniotic Membrane Market Value Share Analysis, by Region, 2018 and 2027
Figure 21: Global Amniotic Membrane Market Attractiveness Analysis, by Region, 2019–2027
Figure 22: North America Amniotic Membrane Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 23: North America Amniotic Membrane Market Value Share Analysis, by Product, 2018 and 2027
Figure 24: North America Amniotic Membrane Market Attractiveness Analysis, by Product, 2019–2027
Figure 25: North America Amniotic Membrane Market Value Share Analysis, by Application, 2018 and 2027
Figure 26: North America Amniotic Membrane Market Attractiveness Analysis, by Application, 2019–2027
Figure 27: North America Amniotic Membrane Market Value Share Analysis, by End User, 2018 and 2027
Figure 28: North America Amniotic Membrane Market Attractiveness Analysis, by End User, 2019–2027
Figure 29: North America Amniotic Membrane Market Value Share Analysis, by Country, 2018 and 2027
Figure 30: North America Amniotic Membrane Market Attractiveness Analysis, by Country, 2019–2027
Figure 31: Europe Amniotic Membrane Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 32: Europe Amniotic Membrane Market Value Share Analysis, by Product, 2018 and 2027
Figure 33: Europe Amniotic Membrane Market Attractiveness Analysis, by Product, 2019–2027
Figure 34: Europe Amniotic Membrane Market Value Share Analysis, by Application, 2018 and 2027
Figure 35: Europe Amniotic Membrane Market Attractiveness Analysis, by Application, 2019–2027
Figure 36: Europe Amniotic Membrane Market Value Share Analysis, by End User, 2018 and 2027
Figure 37: Europe Amniotic Membrane Market Attractiveness Analysis, by End User, 2019–2027
Figure 38: Europe Amniotic Membrane Market Value Share Analysis, by Country/Sub-Region, 2018 and 2027
Figure 39: Europe Amniotic Membrane Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 40: Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 41: Asia Pacific Amniotic Membrane Market Value Share Analysis, by Product, 2018 and 2027
Figure 42: Asia Pacific Amniotic Membrane Market Attractiveness Analysis, by Product, 2017–2027
Figure 43: Asia Pacific Amniotic Membrane Market Value Share Analysis, by Application, 2018 and 2027
Figure 44: Asia Pacific Amniotic Membrane Market Attractiveness Analysis, by Application, 2019–2027
Figure 45: Asia Pacific Amniotic Membrane Market Value Share Analysis, by End User, 2018 and 2027
Figure 46: Asia Pacific Amniotic Membrane Market Attractiveness Analysis, by End User, 2019–2027
Figure 47: Asia Pacific Amniotic Membrane Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 48: Asia Pacific Amniotic Membrane Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 49: Latin America Amniotic Membrane Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 50: Latin America Amniotic Membrane Market Value Share Analysis, by Product, 2018 and 2027
Figure 51: Latin America Amniotic Membrane Market Attractiveness Analysis, by Product, 2019–2027
Figure 52: Latin America Amniotic Membrane Market Value Share Analysis, by Application, 2018 and 2027
Figure 53: North America Amniotic Membrane Market Attractiveness Analysis, by Application, 2019–2027
Figure 54: Latin America Amniotic Membrane Market Value Share Analysis, by End User, 2018 and 2027
Figure 55: Latin America Amniotic Membrane Market Attractiveness Analysis, by End User, 2019–2027
Figure 56: Latin America Amniotic Membrane Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 57: Latin America Amniotic Membrane Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 58: Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 59: Middle East & Africa Amniotic Membrane Market Value Share Analysis, by Product, 2018 and 2027
Figure 60: Middle East & Africa Amniotic Membrane Market Attractiveness Analysis, by Product, 2019–2027
Figure 61: Middle East & Africa Amniotic Membrane Market Value Share Analysis, by Application, 2018 and 2027
Figure 62: Middle East & Africa Amniotic Membrane Market Attractiveness Analysis, by Application, 2019–2027
Figure 63: Middle East & Africa Amniotic Membrane Market Value Share Analysis, by End User, 2018 and 2027
Figure 64: Middle East & Africa Amniotic Membrane Market Attractiveness Analysis, by End User, 2019?2027
Figure 65: Middle East & Africa Amniotic Membrane Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 66: Middle East & Africa Amniotic Membrane Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 67: Global Amniotic Membrane Market Share, by Company, 2018
Figure 68: Integra LifeSciences Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 69: Integra LifeSciences Breakdown of Net Sales, by Geography, 2018
Figure 70: Integra LifeSciences Breakdown of Net Sales, by Product Segment, 2018
Figure 71: Integra LifeSciences R&D Intensity and Sales & Marketing Intensity (%), 2015–2018
Figure 72: MiMedx Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 73: Stryker Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 74: Stryker Breakdown of Net Sales (%), by Region/Country, 2018
Figure 75: Stryker Breakdown of Net Sales (%), by Product Segment, 2018
Figure 76: Stryker R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 77: Osiris Therapeutics, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 78: Osiris Therapeutics, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 79: Osiris Therapeutics, Inc. Breakdown of Net Sales (%), by Product Segment, 2017
